Schedule 6

an approved medical institution (other than an approved community hospital or approved in-patient palliative care institution), with admission date on or after 1 November 2015 but before 1 March 2021$700 per day(aa)an approved medical institution (other than an approved community hospital or approved in-patient palliative care institution), with admission date on or after 1 March 2021 but before 1 April 2025: (i)where admitted as an in‑patient$800 per day, and an additional $200 per day for the first 2 days of each admission(ii)where admitted for day surgical treatment$800 per day(ab)an approved medical institution (other than an approved community hospital or approved in-patient palliative care institution), with admission date on or after 1 April 2025: (i)where admitted or transferred as an in-patient$830 per day, and an additional $800 per day for the first 2 days of each admission(ii)where admitted for day surgical treatment$830 per day(b)an approved community hospital (other than in respect of any approved in-patient palliative care provided by the approved community hospital as an approved in-patient palliative care institution), with admission date on or after 1 November 2015 but before 1 March 2021$350 per day(c)an approved community hospital (other than in respect of any approved in-patient palliative care provided by the approved community hospital as an approved in-patient palliative care institution) for —

rehabilitative care, with an admission date on or after 1 March 2021 but before 1 April 2025 $350 per day(ii)sub-acute care, with an admission date on or after 1 March 2021 but before 1 April 2025 $430 per day(d)an approved community hospital (other than in respect of any approved in-patient palliative care provided by the approved community hospital as an approved in-patient palliative care institution) for —

rehabilitative care, with an admission date on or after 1 April 2025$370 per day(ii)sub-acute care, with an admission date on or after 1 April 2025$570 per day1A.Daily treatment charges for any treatment for or in respect of any illness, disease or impairment (other than any mental illness or personality disorder) (inclusive of prescriptions and professional charges, investigations and other miscellaneous charges, unless listed under any other item) provided by an approved medical institution under the MIC@Home programme, with an admission date on or after 1 April 2025$830 per day, and an additional $800 per day for the first 2 days of each admission2.Daily ward and treatment charges (where admitted as an in-patient or for day surgical treatment) for any treatment for or in respect of any mental illness or personality disorder (inclusive of meal charges, prescriptions and professional charges, investigations and other miscellaneous charges, unless listed under any other item) provided by an approved medical institution, with admission date on or after 1 November 2015 but before 1 March 2021$100 per day up to 35 days per insurance period2A.Daily ward and treatment charges for any treatment for or in respect of any mental illness or personality disorder (inclusive of meal charges, prescriptions and professional charges, investigations and other miscellaneous charges, unless listed under any other item) provided by, with admission date on or after 1 March 2021 but before 1 April 2025 (up to 60 days per insurance period) —

an approved medical institution for day surgical treatment$160 per day(b)the Institute of Mental Health as an in-patient$160 per day(c)an approved medical institution not mentioned in paragraph (b) as an in-patient$1,000 per day for the first 2 days of each admission and $160 per day for the third and subsequent days of each admission2B.Daily ward and treatment charges for any treatment for or in respect of any mental illness or personality disorder (inclusive of meal charges, prescriptions and professional charges, investigations and other miscellaneous charges, unless listed under any other item) provided by, with admission date on or after 1 April 2025 (up to 60 days per insurance period) —

an approved medical institution for day surgical treatment$230 per day(b)the Institute of Mental Health as an in-patient$230 per day(c)an approved medical institution not mentioned in paragraph (b) as an in-patient$1,630 per day for the first 2 days of each admission and $230 per day for the third and subsequent days of each admission3.Daily ward and treatment charges (where admitted as an in-patient) in Intensive Care Unit (inclusive of meal charges, prescriptions and professional charges, investigations and other miscellaneous charges, unless listed under any other item), with admission date on or after 1 November 2015 but before 1 March 2021$1,200 per day3A.Daily ward and treatment charges (where admitted as an in‑patient) in Intensive Care Unit (inclusive of meal charges, prescriptions and professional charges, investigations and other miscellaneous charges, unless listed under any other item), with admission date on or after 1 March 2021 but before 1 April 2025 $2,200 per day, and an additional $200 per day for the first 2 days of each admission3B.Daily ward and treatment charges (where admitted as an in-patient) in Intensive Care Unit (inclusive of meal charges, prescriptions and professional charges, investigations and other miscellaneous charges, unless listed under any other item), with admission date on or after 1 April 2025$5,140 per day, and an additional $800 per day for the first 2 days of each admission4.Surgical Treatment listed in the Table of Surgical Procedures for Medisave Scheme issued by the Ministry of Health, with admission date on or after 1 November 2015 but before 1 January 2020: (a)Table 1$200(b)Table 2$480(c)Table 3$900(d)Table 4$1,150(e)Table 5$1,400(f)Table 6$1,850(g)Table 7$2,0004A.Surgical Treatment listed in the Table of Surgical Procedures issued by the Ministry of Health, with admission date on or after 1 January 2020 but before 1 April 2025: (a)Table 1A$240(b)Table 1B$340(c)Table 1C$340(d)Table 2A$580(e)Table 2B$760(f)Table 2C$760(g)Table 3A$1,060(h)Table 3B$1,160(i)Table 3C$1,280(j)Table 4A$1,540(k)Table 4B$1,580(l)Table 4C$1,640(m)Table 5A$1,800(n)Table 5B$2,180(o)Table 5C$2,180(p)Table 6A$2,360(q)Table 6B$2,360(r)Table 6C$2,360(s)Table 7A$2,600(t)Table 7B$2,600(u)Table 7C$2,6004B.Surgical Treatment listed in the Table of Surgical Procedures issued by the Ministry of Health, with admission date on or after 1 April 2025 (a)Table 1A$240(b)Table 1B$420(c)Table 1C$490(d)Table 2A$760(e)Table 2B$1,120(f)Table 2C$1,120(g)Table 3A$1,390(h)Table 3B$1,740(i)Table 3C$1,920(j)Table 4A$2,310(k)Table 4B$2,370(l)Table 4C$2,460(m)Table 5A$2,700(n)Table 5B$3,270(o)Table 5C$3,270(p)Table 6A$3,540(q)Table 6B$3,540(r)Table 6C$3,540(s)Table 7A$3,900(t)Table 7B$3,900(u)Table 7C$3,9005.Renal dialysis, received as outpatient medical treatment, on or after 1 November 2015 but before 1 March 2021$1,000 per month5A.Renal dialysis, received as outpatient medical treatment, on or after 1 March 2021 but before 1 April 2025 $1,100 per month5B.Renal dialysis, received as outpatient medical treatment, on or after 1 April 2025$1,750 per month6.Surgical implants and approved medical consumables$7,000 per treatment7.Approved cancer drugs administered for treatment of neoplasms, received as outpatient medical treatment, where the approved cancer drugs administered in a month are listed in the CDL under —

in the case of treatment of only one neoplasm — only one of the following categories: (i)Category 1$200 per month(ii)Category 2$400 per month(iii)Category 3$600 per month(iv)Category 4$800 per month(v)Category 5$1,000 per month(vi)Category 6$1,200 per month(vii)Category 7$1,400 per month(viii)Category 8$1,600 per month(ix)Category 9$1,800 per month(x)Category 10$2,000 per month(xa)Category 11$2,200 per month(xi)Category 12$2,400 per month(xia)Category 14$2,800 per month(xii)Category 15$3,000 per month(xiii)Category 16$3,200 per month(xiiia)Category 17$3,400 per month(xiv)Category 18$3,600 per month(xv)Category 21$4,200 per month(xvi)Category 22$4,400 per month(xvii)Category 23$4,600 per month(xviii)Category 25$5,000 per month(xix)Category 33$6,600 per month(xx)Category 34$6,800 per month(xxi)Category 51$10,200 per month(xxii)Category 62$12,400 per month(xxiii)Category 64$12,800 per month(b)in the case of treatment of only one neoplasm — more than one of the categories listed in paragraph (a)The highest amount per month specified in respect of any category of the approved cancer drugs administered in that month(c)in the case of treatment of multiple neoplasms concurrently — only one of the categories listed in paragraph (a) for each neoplasmThe sum of the amount per month specified in respect of the category of the approved cancer drugs administered in that month for each of the neoplasms treated concurrently(d)in the case of treatment of multiple neoplasms concurrently — more than one of the categories listed in paragraph (a) for each neoplasmThe sum of the highest amount per month specified in respect of any category of the approved cancer drugs administered in that month for each of the neoplasms treated concurrently(e)in the case of treatment of multiple neoplasms concurrently — only one of the categories listed in paragraph (a) for at least one neoplasm and more than one of those categories for at least one neoplasmThe sum of —

the amount per month specified in respect of the category of the approved cancer drugs administered in that month for each neoplasm treated with only one of the categories; and

the highest amount per month specified in respect of any category of the approved cancer drugs administered in that month for each neoplasm treated with more than one of the categories7A.Cancer drug treatment (excluding the cost of any cancer drug administered) for only one neoplasm, received as outpatient medical treatment, where treatment is received on or after 1 September 2022 but before 1 January 2023$1,200 per year7B.Any one or both of the following treatments:$3,600 per year(a)Cancer drug treatment (excluding the cost of any cancer drug administered) for only one neoplasm, received as outpatient medical treatment, where treatment is received on or after 1 January 2023 but before 1 June 2026; (b)CTGTP treatment (excluding the cost of any CTGTP administered) for only one neoplasm, received as outpatient medical treatment, where treatment is received on or after 1 October 2025 but before 1 June 2026 7C.Any one or both of the following treatments:$7,200 per year(a)Cancer drug treatment (excluding the cost of any cancer drug administered) for multiple neoplasms concurrently, received as outpatient medical treatment, where treatment is received on or after 1 December 2023 but before 1 June 2026; (b)CTGTP treatment (excluding the cost of any CTGTP administered) for multiple neoplasms concurrently, received as outpatient medical treatment, where treatment is received on or after 1 October 2025 but before 1 June 2026 7D.Any one or both of the following treatments:$4,500 per year(a)Cancer drug treatment (excluding the cost of any cancer drug administered) for only one neoplasm, received as outpatient medical treatment, where treatment is received on or after 1 June 2026; (b)CTGTP treatment (excluding the cost of any CTGTP administered) for only one neoplasm, received as outpatient medical treatment, where treatment is received on or after 1 June 2026 7E.Any one or both of the following treatments:$9,000 per year(a)Cancer drug treatment (excluding the cost of any cancer drug administered) for multiple neoplasms concurrently, received as outpatient medical treatment, where treatment is received on or after 1 June 2026; (b)CTGTP treatment (excluding the cost of any CTGTP administered) for multiple neoplasms concurrently, received as outpatient medical treatment, where treatment is received on or after 1 June 2026 8.Radiotherapy treatment received as outpatient medical treatment: (a)External radiotherapy, where treatment is received on or after 1 November 2015 but before 1 March 2021 $140 per treatment(aa)External radiotherapy (excluding hemi‑body radiotherapy), where treatment is received on or after 1 March 2021 but before 1 April 2025 $300 per treatment(ab)Hemi-body radiotherapy, where treatment is received on or after 1 March 2021 but before 1 April 2025 $900 per treatment(ac)External radiotherapy (excluding hemi-body radiotherapy), where treatment is received on or after 1 April 2025$400 per treatment(ad)Hemi-body radiotherapy, where treatment is received on or after 1 April 2025$620 per treatment(b)Superficial X-ray, where treatment is received on or after 1 November 2015 but before 1 March 2021 $140 per treatment(c)Brachytherapy (with external radiotherapy), where treatment is received before 1 April 2025 $500 per treatment(ca)Brachytherapy (with external radiotherapy), where treatment is received on or after 1 April 2025$620 per treatment(d)Brachytherapy (without external radiotherapy), where treatment is received before 1 April 2025 $500 per treatment(da)Brachytherapy (without external radiotherapy), where treatment is received on or after 1 April 2025$620 per treatment(e)Stereotactic radiotherapy, where treatment is received before 1 April 2025 $1,800 per treatment(ea)Stereotactic radiotherapy, where treatment is received on or after 1 April 2025$460 per treatment(f)Approved proton beam therapy for a Category 1 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 October 2022 but before 1 April 2025 $300 per treatment(fa)Approved proton beam therapy for a Category 1 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 April 2025$400 per treatment(g)Approved proton beam therapy for a Category 2 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 October 2022 but before 1 April 2025 $500 per treatment(ga)Approved proton beam therapy for a Category 2 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 April 2025$620 per treatment(h)Approved proton beam therapy for a Category 3 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 October 2022 but before 1 April 2025 $1,800 per treatment(i)Approved proton beam therapy for a Category 3 clinical indication listed in the Approved Indications for PBT, where treatment is received on or after 1 April 2025$460 per treatment9.Immunosuppressants for organ transplant, received as outpatient medical treatment, where treatment is received on or after 1 November 2015 but before 1 March 2021$200 per month9A.Immunosuppressants for organ transplant, received as outpatient medical treatment, where treatment is received on or after 1 March 2021 but before 1 April 2025 $550 per month9B.Immunosuppressants for organ transplant, received as outpatient medical treatment, where treatment is received on or after 1 April 2025$710 per month10.Erythropoietin drug for chronic renal failure or dialysis treatment, received as outpatient medical treatment before 1 April 2025 $200 per month10A.Erythropoietin drug for chronic renal failure or dialysis treatment, received as outpatient medical treatment on or after 1 April 2025$220 per month11.Radiosurgery treatment, with admission date on or after 1 November 2015 but before 1 March 2021$4,800 per treatment11A.Radiosurgery treatment, with admission date on or after 1 March 2021 but before 1 April 2025 $10,000 per course of treatment11B.Radiosurgery treatment, with admission date on or after 1 April 2025 but before 1 June 2026$15,700 per course of treatment11C.Radiosurgery treatment, received as outpatient medical treatment on or after 1 June 2026$15,700 per course of treatment12.Long term parenteral nutrition, received as outpatient medical treatment before 1 April 2025 $1,700 per month12A.Long term parenteral nutrition, received as outpatient medical treatment on or after 1 April 2025$2,200 per month13.Autologous bone marrow transplant for the treatment of multiple myeloma, received as day treatment patient, with admission date on or after 1 April 2019 but before 1 June 2026$6,000 per treatment13A.Autologous bone marrow transplant for the treatment of multiple myeloma, received as outpatient medical treatment on or after 1 June 2026$6,000 per treatment14.General palliative care received as an in-patient of an approved in-patient palliative care institution, with admission date on or after 1 April 2020 but before 1 February 2024$250 per day14A.General palliative care received as an in‑patient of an approved in‑patient palliative care institution, with admission date on or after 1 February 2024$460 per day15.Specialised palliative care, or a combination of specialised and general palliative care, received as an in-patient of an approved in-patient palliative care institution, with admission date on or after 1 April 2020 but before 1 February 2024$350 per day15A.Specialised palliative care, or a combination of specialised and general palliative care, received as an in‑patient of an approved in‑patient palliative care institution, with admission date on or after 1 February 2024$500 per day16.Any medical treatment under the home ventilation and respiratory support programme, received as outpatient medical treatment on or after 1 October 2025$840 per month17.Life support home care provided to a paediatric patient, received as outpatient medical treatment on or after 1 October 2025$420 per month18.Negative pressure wound therapy, received as outpatient medical treatment on or after 1 October 2025$120 per day19.Repetitive transcranial magnetic stimulation, received as outpatient medical treatment on or after 1 October 2025$120 per treatment session, subject to maximum number of treatment sessions the insured person is entitled to claim under regulation 13(3A)20.Pasteurised donated human milk, received as outpatient medical treatment on or after 1 October 2025$85 per day21.Hyperbaric oxygen therapy, received as outpatient medical treatment on or after 1 October 2025$780 per treatment session22.Parenteral antibiotics therapy, received as outpatient medical treatment on or after 1 October 2025$90 per day23.Approved high-cost drugs administered in relation to the following conditions, received on or after 1 October 2025: (a)Treatment and prophylaxis for haemophilia A$1,400 per month(b)Treatment and prophylaxis for haemophilia B$4,800 per month(c)Treatment for immune thrombocytopenia or refractory severe aplastic anaemia$1,800 per month(d)Treatment for thalassaemia$800 per month(e)Treatment for conditions associated with growth failure in children with short stature$800 per month(f)Treatment for spinal muscular atrophy$7,400 per month(g)Treatment for Fabry disease$4,400 per month(h)Treatment for X-linked hypophosphataemia$6,800 per month24.The following approved CTGTPs, received on or after 1 October 2025: (a)Kymriah$141,000 per course of treatment(b)Yescarta$141,000 per course of treatment[S 632/2025 wef 01/10/2025][S 231/2025 wef 01/04/2025]Note:Where an insured person’s MediShield Life cover is terminated during any calendar month, if the assured amount for any item of approved medical treatment or services received by the insured person during that calendar month or any subsequent calendar month is specified per month in the table, the whole of the assured amount continues to apply to such medical treatment or services received during each of those calendar months.[S 731/2018 wef 01/11/2018][S 286/2019 wef 01/04/2019][S 866/2020 wef 01/01/2020][S 224/2020 wef 01/04/2020][S 135/2021 wef 26/02/2021][S 711/2022 wef 01/09/2022][S 769/2022 wef 01/10/2022][S 28/2023 wef 01/02/2023][S 165/2023 wef 01/04/2023][S 532/2023 wef 01/08/2023][S 532/2023 wef 01/11/2023][S 772/2023 wef 01/12/2023][S 772/2023 wef 01/02/2024][S 323/2026 wef 01/06/2026]